- Exchange: Frankfurt
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Imaging Systems
Snapshot for Positron Corp (PQ7)
| Open: | 0.004 | Day's Range: | 0.004 - 0.004 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 0.005 | 52wk Range: | 0.001 - 0.009 | 1-Yr Rtn: | -33.33% |
Key Statistics for PQ7
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 0 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/21/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for PQ7
Company Profile & Key Executives for PQ7
Positron Corporation is a molecular imaging company focused on Nuclear Cardiology. The Company provides solutions to the Nuclear Medicine community ranging from molecular imaging to radiopharmaceutical technologies. Positron's products include PET imaging system, an automated radiopharmaceutical system, and PET unit dose infusion and shielding system
| Patrick G RooneyChairman/CEO | Corey N ConnChief Financial Officer |
| Charles Conroy "Chuck"Chief Operating Officer | Joseph G OliverioChief Technology Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
PQ7 News
-
Industry News
No stories found
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page